KB Financial Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2K Hold
25
﹤0.01% 493
2023
Q2
$2K Sell
25
-6,460
-100% -$500K ﹤0.01% 511
2023
Q1
$487K Buy
6,485
+878
+16% +$65.3K 0.14% 93
2022
Q4
$442K Sell
5,607
-746
-12% -$55.9K 0.15% 103
2022
Q3
$446K Buy
6,353
+1,106
+21% +$86.7K 0.16% 88
2022
Q2
$420K Sell
5,247
-2,016
-28% -$158K 0.15% 83
2022
Q1
$551K Buy
7,263
+925
+15% +$73.3K 0.15% 66
2021
Q4
$541K Buy
6,338
+1,504
+31% +$117K 0.16% 65
2021
Q3
$365K Buy
4,834
+677
+16% +$53.8K 0.13% 98
2021
Q2
$338K Buy
4,157
+434
+12% +$35.5K 0.13% 98
2021
Q1
$294K Buy
+3,723
New +$292K 0.13% 92

Other funds holding CL

KB Financial Partners's CL Position: Q3 2023 in Review

KB Financial Partners held its Colgate-Palmolive (CL) position steady in Q3 2023 at 25 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

KB Financial Partners first reported a position in CL in Q1 2021 and has held it in 11 quarters since. The position peaked at $551K in Q1 2022. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • KB Financial Partners held 25 shares of Colgate-Palmolive worth $2K as of Q3 2023.
  • KB Financial Partners left its Colgate-Palmolive share count unchanged in Q3 2023.
  • Colgate-Palmolive made up ﹤0.01% of KB Financial Partners's portfolio in Q3 2023, its #493 holding.
  • KB Financial Partners first reported a position in Colgate-Palmolive in Q1 2021 and has held it in 11 quarters since.
  • KB Financial Partners's Colgate-Palmolive position peaked at $551K in Q1 2022.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.